Quest Diagnostics Incorporated (0KSX.L)
USD 152.97
(-2.05%)
USD 152.97
(-2.05%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 5.36 Billion USD | 16.16% |
| 2022 | 4.62 Billion USD | -0.75% |
| 2021 | 4.65 Billion USD | 0.04% |
| 2020 | 4.65 Billion USD | -12.63% |
| 2019 | 5.32 Billion USD | 36.86% |
| 2018 | 3.89 Billion USD | 2.88% |
| 2017 | 3.78 Billion USD | 1.34% |
| 2016 | 3.73 Billion USD | 2.27% |
| 2015 | 3.65 Billion USD | -2.95% |
| 2014 | 3.76 Billion USD | 12.91% |
| 2013 | 3.33 Billion USD | -0.94% |
| 2012 | 3.36 Billion USD | -16.43% |
| 2011 | 4.02 Billion USD | 34.6% |
| 2010 | 2.99 Billion USD | -3.77% |
| 2009 | 3.1 Billion USD | 0.78% |
| 2008 | 3.08 Billion USD | -12.92% |
| 2007 | 3.54 Billion USD | 127.56% |
| 2006 | 1.55 Billion USD | -2.28% |
| 2005 | 1.59 Billion USD | 44.9% |
| 2004 | 1.09 Billion USD | -0.35% |
| 2003 | 1.1 Billion USD | 34.06% |
| 2002 | 822.53 Million USD | 0.1% |
| 2001 | 821.74 Million USD | -19.92% |
| 2000 | 1.02 Billion USD | -15.67% |
| 1999 | 1.21 Billion USD | 161.79% |
| 1998 | 464.8 Million USD | -9.71% |
| 1997 | 514.8 Million USD | -3.92% |
| 1996 | 535.79 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 5.08 Billion USD | -4.93% |
| 2024 Q1 | 5.35 Billion USD | -0.32% |
| 2024 Q3 | 6.25 Billion USD | 36.99% |
| 2023 Q3 | 4.91 Billion USD | -0.95% |
| 2023 Q2 | 4.95 Billion USD | 7.29% |
| 2023 FY | 5.36 Billion USD | 16.16% |
| 2023 Q4 | 5.36 Billion USD | 9.3% |
| 2023 Q1 | 4.62 Billion USD | 0.0% |
| 2022 FY | 4.62 Billion USD | -0.75% |
| 2022 Q3 | 4.64 Billion USD | 0.06% |
| 2022 Q4 | 4.62 Billion USD | -0.39% |
| 2022 Q1 | 4.66 Billion USD | 0.13% |
| 2022 Q2 | 4.63 Billion USD | -0.56% |
| 2021 Q4 | 4.65 Billion USD | 0.15% |
| 2021 Q3 | 4.65 Billion USD | 0.06% |
| 2021 FY | 4.65 Billion USD | 0.04% |
| 2021 Q1 | 4.66 Billion USD | 0.13% |
| 2021 Q2 | 4.64 Billion USD | -0.3% |
| 2020 Q2 | 5.13 Billion USD | 11.92% |
| 2020 Q3 | 5.14 Billion USD | 0.23% |
| 2020 FY | 4.65 Billion USD | -12.63% |
| 2020 Q1 | 4.59 Billion USD | -13.85% |
| 2020 Q4 | 4.65 Billion USD | -9.59% |
| 2019 Q4 | 5.32 Billion USD | 17.23% |
| 2019 FY | 5.32 Billion USD | 36.86% |
| 2019 Q1 | 4.77 Billion USD | 22.71% |
| 2019 Q2 | 4.53 Billion USD | -5.07% |
| 2019 Q3 | 4.54 Billion USD | 0.22% |
| 2018 Q3 | 3.69 Billion USD | -0.4% |
| 2018 FY | 3.89 Billion USD | 2.88% |
| 2018 Q4 | 3.89 Billion USD | 5.27% |
| 2018 Q2 | 3.71 Billion USD | -3.78% |
| 2018 Q1 | 3.85 Billion USD | 1.98% |
| 2017 FY | 3.78 Billion USD | 1.34% |
| 2017 Q2 | 3.73 Billion USD | 0.16% |
| 2017 Q1 | 3.73 Billion USD | -0.08% |
| 2017 Q4 | 3.78 Billion USD | 0.53% |
| 2017 Q3 | 3.76 Billion USD | 0.72% |
| 2016 FY | 3.73 Billion USD | 2.27% |
| 2016 Q1 | 3.89 Billion USD | 6.77% |
| 2016 Q2 | 3.84 Billion USD | -1.44% |
| 2016 Q3 | 3.82 Billion USD | -0.52% |
| 2016 Q4 | 3.73 Billion USD | -2.3% |
| 2015 Q1 | 4.73 Billion USD | 25.76% |
| 2015 Q3 | 3.73 Billion USD | -0.13% |
| 2015 Q4 | 3.65 Billion USD | -2.14% |
| 2015 FY | 3.65 Billion USD | -2.95% |
| 2015 Q2 | 3.73 Billion USD | -21.03% |
| 2014 Q3 | 3.86 Billion USD | -2.37% |
| 2014 FY | 3.76 Billion USD | 12.91% |
| 2014 Q1 | 3.94 Billion USD | 18.46% |
| 2014 Q2 | 3.95 Billion USD | 0.28% |
| 2014 Q4 | 3.76 Billion USD | -2.64% |
| 2013 Q2 | 3.49 Billion USD | 2.8% |
| 2013 Q4 | 3.33 Billion USD | -1.04% |
| 2013 Q3 | 3.36 Billion USD | -3.7% |
| 2013 Q1 | 3.4 Billion USD | 1.12% |
| 2013 FY | 3.33 Billion USD | -0.94% |
| 2012 FY | 3.36 Billion USD | -16.43% |
| 2012 Q1 | 3.91 Billion USD | -2.62% |
| 2012 Q2 | 3.82 Billion USD | -2.47% |
| 2012 Q3 | 3.53 Billion USD | -7.65% |
| 2012 Q4 | 3.36 Billion USD | -4.72% |
| 2011 Q3 | 4.2 Billion USD | -2.86% |
| 2011 Q1 | 4.22 Billion USD | 41.26% |
| 2011 FY | 4.02 Billion USD | 34.6% |
| 2011 Q4 | 4.02 Billion USD | -4.25% |
| 2011 Q2 | 4.32 Billion USD | 2.46% |
| 2010 Q1 | 3.11 Billion USD | 0.25% |
| 2010 FY | 2.99 Billion USD | -3.77% |
| 2010 Q3 | 3.16 Billion USD | 0.72% |
| 2010 Q4 | 2.99 Billion USD | -5.6% |
| 2010 Q2 | 3.14 Billion USD | 0.95% |
| 2009 FY | 3.1 Billion USD | 0.78% |
| 2009 Q1 | 3.08 Billion USD | -0.03% |
| 2009 Q2 | 3.08 Billion USD | 0.02% |
| 2009 Q3 | 2.98 Billion USD | -3.28% |
| 2009 Q4 | 3.1 Billion USD | 4.22% |
| 2008 Q1 | 3.42 Billion USD | -3.2% |
| 2008 FY | 3.08 Billion USD | -12.92% |
| 2008 Q4 | 3.08 Billion USD | -1.44% |
| 2008 Q2 | 3.25 Billion USD | -4.9% |
| 2008 Q3 | 3.12 Billion USD | -4.03% |
| 2007 FY | 3.54 Billion USD | 127.56% |
| 2007 Q1 | 2 Billion USD | 28.88% |
| 2007 Q3 | 3.76 Billion USD | -3.78% |
| 2007 Q4 | 3.54 Billion USD | -5.93% |
| 2007 Q2 | 3.91 Billion USD | 95.09% |
| 2006 Q2 | 1.53 Billion USD | 0.01% |
| 2006 Q3 | 1.55 Billion USD | 1.52% |
| 2006 Q4 | 1.55 Billion USD | 0.0% |
| 2006 Q1 | 1.53 Billion USD | -3.76% |
| 2006 FY | 1.55 Billion USD | -2.28% |
| 2005 Q3 | 854.29 Million USD | 0.01% |
| 2005 Q4 | 1.59 Billion USD | 86.38% |
| 2005 Q2 | 854.23 Million USD | 0.01% |
| 2005 Q1 | 854.19 Million USD | -22.26% |
| 2005 FY | 1.59 Billion USD | 44.9% |
| 2004 FY | 1.09 Billion USD | -0.35% |
| 2004 Q4 | 1.09 Billion USD | -0.29% |
| 2004 Q3 | 1.1 Billion USD | -0.01% |
| 2004 Q2 | 1.1 Billion USD | -0.02% |
| 2004 Q1 | 1.1 Billion USD | -0.03% |
| 2003 FY | 1.1 Billion USD | 34.06% |
| 2003 Q4 | 1.1 Billion USD | -1.67% |
| 2003 Q3 | 1.12 Billion USD | -1.59% |
| 2003 Q2 | 1.13 Billion USD | -6.97% |
| 2003 Q1 | 1.22 Billion USD | 48.93% |
| 2002 Q4 | 822.53 Million USD | -21.5% |
| 2002 FY | 822.53 Million USD | 0.1% |
| 2002 Q3 | 1.04 Billion USD | -6.66% |
| 2002 Q2 | 1.12 Billion USD | 36.64% |
| 2002 Q1 | 821.59 Million USD | -0.02% |
| 2001 Q3 | 958.53 Million USD | -5.51% |
| 2001 FY | 821.74 Million USD | -19.92% |
| 2001 Q4 | 821.74 Million USD | -14.27% |
| 2001 Q1 | 1.02 Billion USD | -0.25% |
| 2001 Q2 | 1.01 Billion USD | -0.89% |
| 2000 Q1 | 1.2 Billion USD | -0.92% |
| 2000 Q2 | 1.19 Billion USD | -0.93% |
| 2000 Q4 | 1.02 Billion USD | -13.67% |
| 2000 FY | 1.02 Billion USD | -15.67% |
| 2000 Q3 | 1.18 Billion USD | -0.49% |
| 1999 Q4 | 1.21 Billion USD | -3.98% |
| 1999 FY | 1.21 Billion USD | 161.79% |
| 1999 Q1 | 416.6 Million USD | -10.37% |
| 1999 Q2 | 399.9 Million USD | -4.01% |
| 1999 Q3 | 1.26 Billion USD | 216.88% |
| 1998 FY | 464.8 Million USD | -9.71% |
| 1998 Q4 | 464.8 Million USD | -1.23% |
| 1998 Q1 | 507.1 Million USD | -1.5% |
| 1998 Q3 | 470.6 Million USD | -3.76% |
| 1998 Q2 | 489 Million USD | -3.57% |
| 1997 Q4 | 514.8 Million USD | -0.12% |
| 1997 Q2 | 515.7 Million USD | 0.0% |
| 1997 Q1 | 515.7 Million USD | -3.79% |
| 1997 FY | 514.8 Million USD | -3.92% |
| 1997 Q3 | 515.4 Million USD | -0.06% |
| 1996 Q4 | 536 Million USD | -56.49% |
| 1996 Q3 | 1.23 Billion USD | 0.0% |
| 1996 FY | 535.79 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Phreesia, Inc. | 11.98 Million USD | -44705.141% |
| Accuray Incorporated | 172.15 Million USD | -3018.683% |
| Align Technology, Inc. | 96.96 Million USD | -5436.878% |
| Elevance Health Inc. | 25.12 Billion USD | 78.627% |
| AxoGen, Inc. | 69.29 Million USD | -7648.369% |
| Boston Scientific Corporation | 9.09 Billion USD | 40.981% |
| CVS Health Corporation | 79.38 Billion USD | 93.237% |
| Cardinal Health, Inc. | 5.6 Billion USD | 4.279% |
| Centene Corporation | 17.69 Billion USD | 69.665% |
| DaVita Inc. | 11.11 Billion USD | 51.702% |
| HCA Healthcare, Inc. | 41.85 Billion USD | 87.174% |
| Hologic, Inc. | 2.53 Billion USD | -111.828% |
| Humana Inc. | 10.21 Billion USD | 47.43% |
| IDEXX Laboratories, Inc. | 947.88 Million USD | -466.422% |
| Laboratory Corporation of America Holdings | 5.95 Billion USD | 9.828% |
| Masimo Corporation | 970 Million USD | -453.505% |
| McKesson Corporation | 5.47 Billion USD | 1.882% |
| Patterson Companies, Inc. | 762.94 Million USD | -603.725% |
| ResMed Inc. | 873.93 Million USD | -514.348% |
| Henry Schein, Inc. | 2.74 Billion USD | -95.877% |
| Teladoc Health, Inc. | 1.59 Billion USD | -237.19% |
| Universal Health Services, Inc. | 5.36 Billion USD | -0.044% |
| Veeva Systems Inc. | 55.77 Million USD | -9526.177% |
| Baxter International Inc. | 14.36 Billion USD | 62.622% |
| Becton, Dickinson and Company | 15.87 Billion USD | 66.188% |
| Intuitive Surgical, Inc. | 89.8 Million USD | -5878.842% |
| Danaher Corporation | 19.35 Billion USD | 72.262% |
| Stryker Corporation | 12.99 Billion USD | 58.684% |
| Medtronic plc | 24.96 Billion USD | 78.492% |